MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Dopamine replacement influences on postural motor learning in Parkinson disease

S. Paul, G. Olivier, C. Walter, S. Schaefer, L. Dibble (Salt Lake City, UT, USA)

Meeting: 2017 International Congress

Abstract Number: 946

Keywords: Basal ganglia, Posture, Rehabilitation

Session Information

Date: Wednesday, June 7, 2017

Session Title: Parkinson's Disease: Cognition

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To determine if i) dopamine replacement affects general and sequence specific learning of a postural task in people with Parkinson disease (PD), and ii) training “on” levodopa medication affects transfer of movement skill to untrained postural tasks compared to training “off” medication.

Background: Background: Impaired motor learning in PD may be due to dopamine deficiency or to overdosing of the basal ganglia with dopamine replacement therapy. Previous research has suggested that exogenous dopamine suppresses activation of the associative striatum during the early acquisition stages of motor learning.[1] However, the clinical relevance of these findings have not been tested on environmentally valid tasks.

Methods: 19 participants with PD were randomised to train on (n=10) or off (n=9) levodopa medication. Participants practiced multiple blocks of stepping task trials over three consecutive days (acquisition period), followed by an initial retention and delayed retention test (2 and 9 days after training, respectively). Each trial consisted of a sequence of 12 random and 12 repeated step sequences presented in a random order across trials. Transfer was assessed using the four square step test and MiniBEST test “on” levodopa before acquisition and at delayed retention.

Results: There were no between group differences in general (p=.28) or sequence specific (p=.06) learning of the postural task, controlling for baseline performance. However, both groups demonstrated improved performance in the stepping task over the acquisition period (p=.03). There was no difference between groups in performance carryover between end of acquisition to either retention session (p=.12–.52) or in transfer to performance of untrained postural tasks (p=.46–.71). [Figure 1]

Conclusions: Dopamine replacement did not differentially affect general or sequence specific learning of a postural task in people with PD. There was a trend for people who trained “on” medication to improve sequence specific learning. Successful learning of postural tasks that challenge stability may improve gait and balance and reduce falls in people with PD. More research is required to determine the practice dose required to improve postural stability in people with PD.

References:

  1. Vaillancourt et al. Dopamine overdose hypothesis: evidence and clinical implications. Mov Disord. 2013;28:1920-9.

To cite this abstract in AMA style:

S. Paul, G. Olivier, C. Walter, S. Schaefer, L. Dibble. Dopamine replacement influences on postural motor learning in Parkinson disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/dopamine-replacement-influences-on-postural-motor-learning-in-parkinson-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/dopamine-replacement-influences-on-postural-motor-learning-in-parkinson-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley